1,2,3,5-tetrahydrobenzo'c!azepin-4-one derivatives having muscarinic antagonist activity
申请人:——
公开号:US20030199494A1
公开(公告)日:2003-10-23
There is disclosed a compound having the formula or a pharmaceutically acceptable salt thereof, wherein: R
1a
, R
1b
and R
1c
are independently fluorine or hydrogen; R
2
is C
1
to C
12
alkyl being straight or branched chain, saturated or unsaturated, mono-substituted or unsubstituted, said substituents being selected from piperidine, pyrroliding, morpholine, thiomorpholine and cycloalkyl of 3 to 7 carbon atoms; a cycloalkyl of 3 to 9 carbon atoms; a cycloalkyl of 3 to 9 carbon atoms having a C
1
to C
6
alkyl substituent; a polycycloalkyl of 2 to 3 rings having 7 to 12 carbons; and phenyl or phenyl substituted with halogen, hydroxy, C
1
to C
6
alkoxy, C
1
to C
6
alkyl, nitro, methylene dioxy or trifluoromethyl; and R
3
is a moiety selected from: (I), (II) or a pyrrolidin-3-yl moiety of the formula (III). The compounds are disclosed for use as muscarinic antagonists with M
3
selectivity.
揭示了一种具有以下结构式或其药用可接受盐的化合物,其中:R1a、R1b和R1c独立地是氟或氢;R2是C1到C12的直链或支链、饱和或不饱和、单取代或未取代的烷基,所述取代基被选择自哌啶、吡咯啶、吗啉、硫代吗啉和3到7个碳原子的环烷基;3到9个碳原子的环烷基;3到9个碳原子的环烷基,具有C1到C6烷基取代基;具有7到12个碳原子的2到3环多环烷基;以及苯或苯被卤素、羟基、C1到C6烷氧基、C1到C6烷基、硝基、亚甲二氧基或三氟甲基取代的苯;R3是从(I)、(II)或具有结构式(III)的吡咯啉-3-基团中选择的基团。这些化合物被用作具有M3选择性的毒蕈碱拮抗剂。